BRVE Braveheart Bio, Inc.

Fundamentals / CIK 0002131524 / USD

Braveheart Bio, Inc. reported $514.5M in total assets through September 30, 2026 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open BRVE in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

No annual income statement rows are available in SEC EDGAR CompanyFacts for BRVE.

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-09-30 2025-06-30 2025-03-31
Research & Development $17.54M $11.12M -- $9.0K $0 --
Total Operating Expenses $30.15M $15.88M -- $59.29M $381K --
Operating Income -$30.15M -$15.88M -- -$59.29M -$381K --
Interest Income $3.71M $889K -- $169K $0 --
Net Income -$26.50M -$14.99M -$14.28M -$59.12M -$381K -$99K
Basic EPS -$0.51 -$10.99 -- -$10.05 -$0.61 --
Diluted EPS -$0.51 -$10.99 -- -$10.05 -$0.61 --
Basic Shares Outstanding 52.1M 1.7M -- 5.9M 637.5K --
Diluted Shares Outstanding 52.1M 1.7M -- 5.9M 637.5K --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

No annual balance sheet rows are available in SEC EDGAR CompanyFacts for BRVE.

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2025-12-31
Cash & Cash Equivalents $121.3M $122.8M $89.16M
Cash & Short-Term Investments $503.5M $122.8M $89.16M
Total Current Assets $359.6M $123.4M $89.28M
Property, Plant & Equipment, Net $20K $23K $0
Other Non-Current Assets $98K $70K $70K
Total Non-Current Assets $154.9M $3.51M $70K
Total Assets $514.5M $127.0M $89.35M
Accounts Payable $1.98M $2.67M $1.06M
Other Current Liabilities $6.14M -- $0
Total Current Liabilities $16.67M $9.06M $5.24M
Other Non-Current Liabilities $75K $86K $91K
Total Non-Current Liabilities $175K $284K $91K
Total Liabilities $16.85M $9.34M $5.33M
Total Debt (incl. Leases) $515K $575K --
Common Stock $8.0K $1.0K $1.0K
Retained Earnings -$122.4M -$95.91M -$66.05M
Accumulated Other Comp. Income -$718K -- $0
Total Stockholders' Equity $497.6M -$95.91M -$65.87M
Total Equity $497.6M -$95.91M -$65.87M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

No annual cash flow statement rows are available in SEC EDGAR CompanyFacts for BRVE.

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-09-30 2025-06-30 2025-03-31
Net Income -$26.50M -$14.99M -$14.28M -$59.12M -$381K -$99K

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

No annual ratios & growth rows are available in SEC EDGAR CompanyFacts for BRVE.

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-09-30 2025-06-30 2025-03-31
Current Ratio 21.57x 13.63x -- -- -- --
Quick Ratio 30.20x 13.56x -- -- -- --
Debt to Equity 0.00x -- -- -- -- --
Source: SEC EDGAR CompanyFacts (CIK 0002131524) · from March 31, 2025 Data through September 30, 2026 · synced Nov 20, 2026, 05:27 UTC · Open in terminal